Delek US Energy stock hits 52-week high at 54.2 USD
Delek US Energy Inc. stock recently hit a 52-week high of $54.20 and is currently trading just below this peak. The stock has seen a 126.39% increase over the past year and analysts predict profitability for 2026, with several firms upgrading their ratings and increasing price targets due to strategic initiatives and favorable market conditions. The company has also amended its term loan credit agreement and its subsidiary Delek Logistics Partners has received significant tenders for its senior notes.
Can Delek's Big Spring Upgrade Deliver Better Refining Margins?
Delek US Holdings (DK) recently completed a significant turnaround at its Big Spring refinery, which was executed on schedule and within budget. This upgrade aims to enhance the refinery's reliability, crude slate optimization, and product yields, positioning Delek to capitalize on healthy refining fundamentals and geopolitical disruptions. The company's stock has outperformed its sub-industry, and analysts have revised 2026 EPS estimates sharply higher, indicating strong near-term earnings expectations.
Counterpoint Mutual Funds LLC Cuts Position in Delek US Holdings, Inc. $DK
Counterpoint Mutual Funds LLC significantly reduced its stake in Delek US Holdings, Inc. by 92% in the first quarter, now holding 8,516 shares valued at $384,000. This comes despite Delek US reporting stronger-than-expected quarterly earnings and revenue. The stock has a "Hold" rating with an average target price of $46.08, though some analysts have raised price targets.
If You Invested $1,000 in Delek Us Hldgs Inc (DK)
This article analyzes the historical performance of Delek US Holdings Inc. (DK) stock, detailing hypothetical returns for investments of $1,000 over 1, 5, and 10 years, and includes a year-by-year return breakdown. It also provides an overview of Delek US Holdings, describing its operations in petroleum refining and logistics through Delek Logistics Partners, LP, its financial metrics, regulatory environment, and capital allocation strategies. The company's performance is compared to the S&P 500, showing that DK has outperformed the benchmark over the past decade.
Executive reshuffle at Delek (NYSE: DKL) with new GC, pay changes
Delek US Holdings and Delek Logistics are implementing executive and compensation changes effective July 1, 2026. Robert Wright is promoted to CFO of Delek US and receives a pay increase, while Misty Lavender becomes the new General Counsel. Outgoing GC Denise McWatters will transition to a two-year consulting role.
Zacks.com featured highlights include Neurocrine Biosciences, MYR Group, Block, Delek US Holdings and Dycom Industries
This article highlights five stocks with strong relative price strength for investors to consider in the second half of 2026: Neurocrine Biosciences (NBIX), MYR Group (MYRG), Block (XYZ), Delek US Holdings (DK), and Dycom Industries (DY). These companies are identified based on their outperformance compared to peers and the broader market, strong fundamentals, and positive analyst earnings estimate revisions.
Insider Selling: Delek US (NYSE:DK) Director Sells 5,000 Shares of Stock
Delek US Holdings (NYSE:DK) director William Finnerty sold 5,000 shares of the company's stock on June 29th for a total of $257,500. This sale, conducted under a pre-arranged Rule 10b5-1 trading plan, reduced his direct ownership by 12.56%. The shares were sold at an average price of $51.50, while Delek US stock has recently rallied to $53.18, near its 52-week high, and analysts' consensus remains "Hold" with an average target price of $46.08.
Insider Sell: William Finnerty Sells 5,000 Shares of Delek US Ho
William Finnerty, a Director at Delek US Holdings Inc (DK), sold 5,000 shares of the company, reducing his holdings to 34,805 shares. This transaction follows a pattern of insider selling, with 0 insider buys and 29 insider sells at Delek US Holdings over the past year. The company's stock is considered significantly overvalued at $51.5 per share, with a GF Value of $19.91, indicating a price-to-GF-Value ratio of 2.59.
Delek US Holdings director William Finnerty sells $257,500 in stock
Delek US Holdings director William J. Finnerty sold 5,000 shares of common stock for $257,500 on June 29, 2026, as part of a pre-arranged trading plan. This transaction occurred while the stock was near its 52-week high after returning 137% over the past year. Following the sale, Finnerty directly holds 34,805 shares, and the company has seen positive analyst upgrades and strategic financial developments alongside its strong stock performance.
Delek US (DK) director sells 5,000 shares under Rule 10b5-1 plan
Delek US Holdings director William J. Finnerty sold 5,000 shares of Common Stock at $51.50 each on June 29, 2026, under a pre-arranged Rule 10b5-1 trading plan. After this transaction, Finnerty still directly holds 34,805 shares. This sale is considered routine and has limited informational value regarding his outlook on the stock, given his substantial remaining equity.
Zacks Research Analysts Lift Earnings Estimates for Delek US
Zacks Research has increased its Q2 2026 EPS estimate for Delek US (NYSE:DK) to $0.61 from $0.58 and maintained a "Strong-Buy" rating. This adjustment reflects an improvement in longer-term earnings expectations, further supported by the company's recent beat on quarterly earnings and revenue estimates. Despite a mixed Wall Street sentiment, recent upgrades from TD Cowen and Mizuho suggest a more positive outlook for the oil and gas company.
Hsbc Holdings PLC Sells 22,550 Shares of Delek US Holdings, Inc. $DK
HSBC Holdings PLC reduced its stake in Delek US Holdings, Inc. by 30.2% in the fourth quarter, selling 22,550 shares and retaining 52,204 shares worth approximately $1.56 million. Insider selling has also been noted, with executives selling over $1.57 million worth of shares in the last 90 days. Despite a "Hold" consensus rating from analysts, Delek US recently exceeded earnings and revenue expectations, and the average price target is $46.08.
Delek US Energy stock hits 52-week high at 50.77 USD
Delek US Energy (DK) stock reached a new 52-week high of $51.52, after an impressive 11.5% gain over the past week and a 132.7% return over the last year. Despite this growth, InvestingPro analysis suggests the stock remains undervalued with a Fair Value of $55.34. Recent positive developments include an upgrade to a Buy rating by TD Cowen, a lowered term loan principal, and raised price targets from Goldman Sachs and Raymond James, reflecting strong market positioning and strategic initiatives.
TD Cowen upgrades Delek US stock rating on exemption potential By Investing.com
TD Cowen has upgraded Delek US Holdings Inc. (NYSE:DK) from Hold to Buy, raising its price target to $58 due to potential small refinery exemptions and strong refining market conditions. The firm believes the stock is undervalued, and analysts predict profitability this year. This upgrade follows a mixed first quarter for Delek US, with an unexpected loss per share but higher-than-anticipated revenue.
Delek US Energy stock hits 52-week high at 50.77 USD
Delek US Energy Inc.'s stock reached a 52-week high of $50.77, climbing further to $51.52, driven by strategic initiatives and market positioning, and a 11.5% gain over the past week. This surge is supported by positive analyst upgrades from TD Cowen, Goldman Sachs, and Raymond James, and strategic financial moves like amenity to its term loan credit agreement and tenders for Delek Logistics Partners' notes. These indicate a strong outlook for the company in the energy sector.
[144] Delek US Holdings, Inc. SEC Filing
This article announces an SEC Form 144 filing by Delek US Holdings, Inc. (DK). The filing indicates a proposed sale of 5,000 shares of common stock by an unnamed person for whose account the securities are to be sold, with an aggregate market value of $239,100.00. The shares were acquired as Restricted Stock Units on December 12, 2015.
TD Cowen upgrades Delek US stock rating on exemption potential By Investing.com
TD Cowen upgraded Delek US Holdings Inc. (NYSE:DK) from Hold to Buy, increasing its price target to $58 due to the potential for small refinery exemptions which could add $18 per share. The firm highlighted benefits from strong refining market conditions, reduced interest expenses, and improvements under the company's business improvement program. Delek US recently reported mixed Q1 2026 earnings but has seen its price target raised by other firms like Goldman Sachs and Raymond James, reflecting strategic and financial adjustments.
Delek US (NYSE:DK) Share Price Passes Above Two Hundred Day Moving Average - Here's Why
Delek US (NYSE:DK) shares have risen above their 200-day moving average, trading at $47.66 with a 1% gain. The company recently reported strong quarterly results, exceeding EPS and revenue expectations. Analyst sentiment is mixed, with an average "Hold" rating and a consensus price target of $45.00, while insider transactions show some selling activity.
Price to earnings forward of Delek US Holdings, Inc. – NYSE:DK
This article provides financial information for Delek US Holdings, Inc. (NYSE: DK), focusing on its forward price-to-earnings ratio. It presents a high-level overview of the company's financial data available on TradingView, indicating no current trades at market close.
Delek US Holdings Inc Actuals & Estimates (BOATS:DK)
This article provides an overview of Delek US Holdings Inc. (DK) stock on the BOATS exchange, including financial actuals and analyst estimates. It covers key financial metrics like earnings, revenue, net income, and EBITDA, along with dividend information and employee count. The article also touches on stock forecasts, historical price data, and upcoming earnings dates for DK.
Delek US Holdings (DK) Receives a Buy from Wells Fargo
Wells Fargo maintained a Buy rating on Delek US Holdings (DK) with a price target of $59.00. The company reported quarterly revenue of $2.65 billion and a GAAP net loss of $201.3 million for the quarter ending March 31. Corporate insider sentiment is negative, with an increase in insider selling of shares.
Delek US Holdings Insiders Sold US$6.7m Of Shares Suggesting Hesitancy
The article reports that insiders at Delek US Holdings (NYSE:DK) have sold US$6.7 million worth of shares over the past year, indicating a potential lack of confidence, despite the stock price rising by 21%. These insider sales, primarily exercised options that were then sold, suggest that insiders believe the stock may be fully valued or face future challenges. While insider buying can be a strong signal, significant selling can imply that not all insiders are optimistic about future prospects.
Delek US Holdings Stock - Long-term strategy in a volatile refining market
Delek US Holdings is an integrated downstream energy company that operates in the US, focusing on refining, logistics, and retail. The article discusses their long-term strategy, which emphasizes disciplined capital allocation, shareholder returns, and maintaining manageable leverage in a volatile US fuels market. As of June 20, 2026, their stock (DK) traded on the NYSE in the low-$40 range.
Delek US Holdings, Inc. $DK Shares Sold by River Road Asset Management LLC
River Road Asset Management LLC reduced its stake in Delek US Holdings (NYSE:DK) by 25.3% in the fourth quarter, selling 860,940 shares and now owning 2.55 million shares worth approximately $75.6 million. Additionally, Delek US executives Reuven Spiegel and Robert G. Wright sold shares in May, contributing to a total of 34,270 shares sold by insiders over three months. Analyst ratings are mixed, with an average "Hold" rating and a consensus price target of $45.00, while the company recently beat earnings expectations.
Clifford Capital Partners LLC Sells 232,890 Shares of Delek US Holdings, Inc. $DK
Clifford Capital Partners LLC reduced its stake in Delek US Holdings (NYSE:DK) by 38.4% in the fourth quarter, selling 232,890 shares and retaining 373,769 shares valued at approximately $11.1 million. Despite this, Delek US reported better-than-expected quarterly results, with an EPS of $0.08 against an estimated loss and revenue of $2.65 billion. The stock's current average analyst rating is "Hold" with a target price of $45, while it recently traded around $42.37.
Why Delek US Holdings quietly leans on its RINS management service
Delek US Holdings offers a RINS management service that provides smaller refiners, traders, and obligated parties a way to efficiently navigate complex biofuel compliance and reduce costs. This service, which capitalizes on Delek's market expertise and physical operations, helps clients source, trade, and retire Renewable Identification Numbers (RINs) required by the Renewable Fuel Standard. While offering advantages like reduced execution risk and scale, potential drawbacks include dependency risk and possible competitive concerns for some clients.
Delek US Holdings Inc (DK) Earnings Forecast: Future EPS & Revenue Growth Estimates
Delek US Holdings Inc (DK) currently has an earnings forecast score of 6.71, ranking 81st in the Oil & Gas industry. Analysts have set an average price target of $42.00, with an expected revenue of $3.62 billion for the next quarter and an anticipated EPS of $2.81. The majority of 14 analysts surveyed recommend a "Hold" trend for the stock.
Delek vs. Marathon Petroleum: Which Stock Offers Better Refining Bet?
This article compares Delek US Holdings, Inc. and Marathon Petroleum Corporation as investment opportunities in the oil and gas refining and marketing industry. Marathon Petroleum is highlighted as the stronger investment due to its larger scale, integrated business model, and stable cash flows from its midstream subsidiary, MPLX, justifying its Zacks Rank #1 (Strong Buy). Delek, despite operational improvements, is seen as more exposed to market volatility and is rated Zacks Rank #3 (Hold).
Alberta Investment Management Corp Makes New $7.19 Million Investment in Delek US Holdings, Inc. $DK
Alberta Investment Management Corp initiated a new $7.19 million position in Delek US Holdings, Inc. during the fourth quarter, acquiring 242,300 shares, representing 0.40% of the company. This investment follows Delek US reporting stronger-than-expected first-quarter earnings and revenue, though the stock has received mixed analyst sentiment, with a consensus "Hold" rating and a target price of $45. Meanwhile, company insiders have been engaged in share selling.
Healthcare of Ontario Pension Plan Trust Fund Buys 879,900 Shares of Delek US Holdings, Inc. $DK
Healthcare of Ontario Pension Plan Trust Fund significantly increased its stake in Delek US Holdings, Inc. (NYSE:DK) by 1,173.2% in the fourth quarter, purchasing an additional 879,900 shares to bring its total holdings to 954,900 shares valued at approximately $28.3 million. This increase in institutional ownership comes as several analysts have raised their price targets and Goldman Sachs upgraded the stock to "buy." Delek US (NYSE:DK) also recently reported better-than-expected quarterly earnings and declared a quarterly dividend.
Dockside LLC Invests $884,000 in Delek US Holdings, Inc. $DK
Dockside LLC has disclosed a new fourth-quarter position in Delek US Holdings, acquiring 29,800 shares valued at approximately $884,000. Delek US recently reported strong quarterly results, exceeding EPS and revenue expectations. Despite mixed analyst sentiment with an average "Hold" rating, institutional investors are actively trading the stock, and the company announced a quarterly dividend.
Delek US Holdings, Inc. (NYSE:DK) Given Average Recommendation of "Hold" by Brokerages
Delek US Holdings, Inc. (NYSE:DK) has received a consensus "Hold" rating from brokerages, with an average 12-month price target of $45.00. The company recently reported better-than-expected quarterly earnings and revenue, and continues to pay a quarterly dividend, yielding 2.2%. Despite strong financial performance, insider selling and the stock nearing its 52-week high contribute to the mixed analyst sentiment.
Director at Delek US (DK) receives 3,436-share stock grant, now holds 10,082
Delek US Holdings, Inc. director Zohar Shlomo was granted 3,436 shares of common stock at $48.01 per share as a compensation-related award. This transaction, reported in a Form 4 filing, increases his direct holdings to 10,082 common shares. The filing indicates a moderate impact and a neutral sentiment.
Delek US (DK) director awarded 3,436 common shares in Form 4
Delek US Holdings director Richard J. Marcogliese was granted 3,436 shares of common stock at a price of $48.01 per share. This transaction, classified as a grant or other acquisition, increases his direct holdings to 55,763 common shares. The Form 4 filing details this compensation-related award rather than an open-market purchase.
Delek US (NYSE: DK) director awarded 3,436 common shares in stock grant
Delek US Holdings director Christine Benson Schwartzstein was granted 3,436 shares of common stock on June 10, 2026, valued at $48.01 per share. This equity award, not an open-market purchase, increased her direct ownership to 18,613 shares of Delek US common stock. The transaction was detailed in a Form 4 SEC filing, providing transparency on insider holdings.
Director Vicky Sutil receives 3,436 Delek US (DK) common shares
Delek US Holdings director Vicky Sutil was awarded 3,436 shares of common stock as an equity grant, valued at $48.01 per share. This transaction, classified as an acquisition under code A, increases her direct holdings to 32,804 shares. The award represents routine stock-based compensation rather than an open-market trade.
Director at Delek US (NYSE: DK) receives 3,436-share stock grant
Delek US Holdings director William J. Finnerty was granted 3,436 shares of common stock on June 10, 2026, at a price of $48.01 per share as compensation. This transaction, reported via a Form 4 filing, increased his direct ownership to 39,805 shares. The filing did not report any sales or derivative transactions by the director.
Director Laurie Tolson receives 3,436-share stock grant at Delek US (NYSE: DK)
Delek US Holdings, Inc. director Laurie Z. Tolson received a grant of 3,436 shares of common stock on June 10, 2026. The grant, valued at $48.01 per share, increases her direct holdings to 21,662 shares and is a compensation-related award, not an open-market purchase. This information was reported in a Form 4 filing.
Delek US (NYSE: DK) director receives 3,436-share stock award and ownership correction
Delek US Holdings director Gary M. Sullivan Jr. received an award of 3,436 shares of common stock on June 10, 2026, priced at $48.01 per share. Post-award and an administrative correction of 500 shares, his beneficial ownership totals 59,692 shares. This transaction was a compensation-related grant, not an open-market purchase, and included an adjustment to rectify a previous bookkeeping error.
Delek US Holdings, Inc. Stock 12‑Month Price Target Raised to $51.15, Implies 9% Upside
Delek US Holdings, Inc. (DK) has seen its average 12-month stock price target raised to $51.15, up from $50.85, according to 13 analysts. This new target suggests a potential upside of approximately 9% based on the recent closing price. The consensus analyst rating for the stock remains a "Buy" from 14 covering analysts.
Delek US (NYSE: DK) EVP has 1,024 shares withheld for taxes
Delek US Holdings Executive Vice President Robert G. Wright had 1,024 shares of common stock withheld to cover tax obligations upon the vesting of equity awards, valued at $46.55 per share. After this transaction, Wright directly holds 47,124 shares, and the filing indicated no open-market purchases or sales. This was a routine tax-related disposition, not an open-market sale.
Delek US Holdings (DK) Stock Analysis: Surgical Refining Strategy Drives 64% YTD Gain - News and Statistics
Delek US Holdings (NYSE: DK), a refiner with a market capitalization under $3 billion, has seen its stock gain 64% year-to-date, despite often being overlooked compared to larger refiners. The company distinguishes itself with a "surgical" refining strategy, focusing on operational efficiencies and overhead reduction, which contributed to a fivefold increase in EBITDA in the first quarter without a proportional rise in revenue. Wall Street is becoming more aware of Delek, covered by 13 sell-side analysts, suggesting its undervalued status may change.
How Delek's Strong Enterprise Optimization Plan Boosts Its Cash Flow
Delek US Holdings, Inc. (DK) has significantly strengthened its cash flow generation through its Enterprise Optimization Plan (EOP). This initiative, which focuses on operational efficiency, cost reduction, and asset performance, has led to increased annual run-rate targets and contributed substantially to profits. The EOP helps Delek produce higher free cash flow without major capital investments, similar to strategies employed by other refining companies like Phillips 66 and Marathon Petroleum.
Norges Bank Buys New Position in Delek US Holdings, Inc. $DK
During the fourth quarter, Norges Bank initiated a new stake in Delek US Holdings, acquiring 1,630,950 shares valued at approximately $48.4 million, representing about 2.72% of the company. Other institutional investors like Vanguard, Barclays, and Geode also increased their holdings, contributing to 97.01% institutional ownership. Analysts maintain a "Hold" consensus rating with a $44.69 average price target, despite recent upgrades from some firms as the stock traded around $48.36.
BNP Paribas Financial Markets Has $13.15 Million Stake in Delek US Holdings, Inc. $DK
BNP Paribas Financial Markets reduced its stake in Delek US Holdings by 27.7% in the fourth quarter, but still holds 443,465 shares valued at $13.15 million. Delek US reported better-than-expected quarterly results, with earnings of $0.08 per share and revenue of $2.65 billion, surpassing analyst estimates. Analysts currently have a "Hold" rating on the stock with an average target price of $44.69, while noting recent insider sales and a quarterly dividend of $0.255 per share.
Delek US Holdings director sells $89,808 in company stock By Investing.com
Vicky Sutil, a director at Delek US Holdings, sold $89,808 worth of company stock by disposing of 1,871 shares at $48.0 each. This sale occurred on June 3, 2026, as the stock traded near its 52-week high, following a 160% return over the past year. Despite the sale, Ms. Sutil still holds 29,368 shares, and InvestingPro analysis suggests the stock is undervalued, while analysts like Goldman Sachs and Raymond James have raised their price targets for Delek.
36,837 Shares in Delek US Holdings, Inc. $DK Acquired by Highbridge Capital Management LLC
Highbridge Capital Management LLC recently acquired 36,837 shares of Delek US Holdings, Inc. (NYSE:DK), valued at approximately $1.09 million, representing a new stake in the company. While institutional ownership remains high, insider activity has shown sales, yet Delek US recently surpassed earnings and revenue estimates and offers a 2.1% dividend yield. Analyst ratings are mixed, with some firms raising price targets and EPS estimates, while Zacks maintains a "Hold" rating, leading to a consensus "Hold" with a target price of $44.69.
Delek US (NYSE:DK) Director Vicky Sutil Sells 1,871 Shares
Delek US Director Vicky Sutil sold 1,871 shares of Delek US (NYSE:DK) stock on June 3rd at an average price of $48.00, totaling $89,808. Following this and prior sales in May and early June, her position decreased by 5.99%. The company recently reported better-than-expected quarterly results and pays a quarterly dividend of $0.255 per share.
Director Sutil sells 1,871 Delek US (NYSE: DK) shares in open market
Vicky Sutil, a director at Delek US (NYSE: DK), sold 1,871 shares of the company's common stock on June 3, 2026, at a price of $48.00 per share. This open-market transaction reduced her direct holdings to 29,368 shares. The sale was reported in a Form 4 filing with the SEC.
Delek US Holdings director sells $89,808 in company stock
Vicky Sutil, a director at Delek US Holdings, Inc. (NYSE:DK), sold 1,871 shares of the company's common stock for a total of $89,808 on June 3, 2026. This transaction occurred while the stock traded near its 52-week high, following a 160% return over the past year. Post-sale, Ms. Sutil directly holds 29,368 shares, and the company has recently reported mixed Q1 2026 earnings, exceeded revenue expectations, and seen analyst price target increases citing operational improvements.
